Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 269

1.

Retention of in vitro and in vivo BMP-2 bioactivities in sustained delivery vehicles for bone tissue engineering.

Kempen DH, Lu L, Hefferan TE, Creemers LB, Maran A, Classic KL, Dhert WJ, Yaszemski MJ.

Biomaterials. 2008 Aug;29(22):3245-52. doi: 10.1016/j.biomaterials.2008.04.031. Epub 2008 May 9.

2.

Non-invasive monitoring of BMP-2 retention and bone formation in composites for bone tissue engineering using SPECT/CT and scintillation probes.

Kempen DH, Yaszemski MJ, Heijink A, Hefferan TE, Creemers LB, Britson J, Maran A, Classic KL, Dhert WJ, Lu L.

J Control Release. 2009 Mar 19;134(3):169-76. doi: 10.1016/j.jconrel.2008.11.023. Epub 2008 Dec 3.

3.

Enhancement of ectopic bone formation by bone morphogenetic protein-2 released from a heparin-conjugated poly(L-lactic-co-glycolic acid) scaffold.

Jeon O, Song SJ, Kang SW, Putnam AJ, Kim BS.

Biomaterials. 2007 Jun;28(17):2763-71. Epub 2007 Mar 12.

PMID:
17350678
4.

Effect of autologous bone marrow stromal cell seeding and bone morphogenetic protein-2 delivery on ectopic bone formation in a microsphere/poly(propylene fumarate) composite.

Kempen DH, Kruyt MC, Lu L, Wilson CE, Florschutz AV, Creemers LB, Yaszemski MJ, Dhert WJ.

Tissue Eng Part A. 2009 Mar;15(3):587-94. doi: 10.1089/ten.tea.2007.0376.

5.

Bone regeneration using a microstereolithography-produced customized poly(propylene fumarate)/diethyl fumarate photopolymer 3D scaffold incorporating BMP-2 loaded PLGA microspheres.

Lee JW, Kang KS, Lee SH, Kim JY, Lee BK, Cho DW.

Biomaterials. 2011 Jan;32(3):744-52. doi: 10.1016/j.biomaterials.2010.09.035. Epub 2010 Oct 8.

PMID:
20933279
6.

Enhancement of bone growth by sustained delivery of recombinant human bone morphogenetic protein-2 in a polymeric matrix.

Woo BH, Fink BF, Page R, Schrier JA, Jo YW, Jiang G, DeLuca M, Vasconez HC, DeLuca PP.

Pharm Res. 2001 Dec;18(12):1747-53. Erratum in: Pharm Res. 2003 Feb;20(2):334.

PMID:
11785696
7.

Controlled drug release from a novel injectable biodegradable microsphere/scaffold composite based on poly(propylene fumarate).

Kempen DH, Lu L, Kim C, Zhu X, Dhert WJ, Currier BL, Yaszemski MJ.

J Biomed Mater Res A. 2006 Apr;77(1):103-11.

PMID:
16392139
8.

Using poly(lactic-co-glycolic acid) microspheres to encapsulate plasmid of bone morphogenetic protein 2/polyethylenimine nanoparticles to promote bone formation in vitro and in vivo.

Qiao C, Zhang K, Jin H, Miao L, Shi C, Liu X, Yuan A, Liu J, Li D, Zheng C, Zhang G, Li X, Yang B, Sun H.

Int J Nanomedicine. 2013;8:2985-95. doi: 10.2147/IJN.S45184. Epub 2013 Aug 13.

9.

Controlled release by biodegradable hydrogels enhances the ectopic bone formation of bone morphogenetic protein.

Yamamoto M, Takahashi Y, Tabata Y.

Biomaterials. 2003 Nov;24(24):4375-83.

PMID:
12922150
10.

Enhanced bone morphogenetic protein-2-induced ectopic and orthotopic bone formation by intermittent parathyroid hormone (1-34) administration.

Kempen DH, Lu L, Hefferan TE, Creemers LB, Heijink A, Maran A, Dhert WJ, Yaszemski MJ.

Tissue Eng Part A. 2010 Dec;16(12):3769-77. doi: 10.1089/ten.TEA.2010.0173. Epub 2010 Sep 9.

11.

A differential effect of bone morphogenetic protein-2 and vascular endothelial growth factor release timing on osteogenesis at ectopic and orthotopic sites in a large-animal model.

Geuze RE, Theyse LF, Kempen DH, Hazewinkel HA, Kraak HY, Oner FC, Dhert WJ, Alblas J.

Tissue Eng Part A. 2012 Oct;18(19-20):2052-62. doi: 10.1089/ten.TEA.2011.0560. Epub 2012 Sep 12.

13.

Repair of an osteochondral defect by sustained delivery of BMP-2 or TGFβ1 from a bilayered alginate-PLGA scaffold.

Reyes R, Delgado A, Sánchez E, Fernández A, Hernández A, Evora C.

J Tissue Eng Regen Med. 2014 Jul;8(7):521-33. doi: 10.1002/term.1549. Epub 2012 Jun 26.

PMID:
22733683
14.

Novel glycidyl methacrylated dextran (Dex-GMA)/gelatin hydrogel scaffolds containing microspheres loaded with bone morphogenetic proteins: formulation and characteristics.

Chen FM, Zhao YM, Sun HH, Jin T, Wang QT, Zhou W, Wu ZF, Jin Y.

J Control Release. 2007 Mar 12;118(1):65-77. Epub 2006 Nov 24.

PMID:
17250921
15.

Biodegradable gelatin microparticles as delivery systems for the controlled release of bone morphogenetic protein-2.

Patel ZS, Yamamoto M, Ueda H, Tabata Y, Mikos AG.

Acta Biomater. 2008 Sep;4(5):1126-38. doi: 10.1016/j.actbio.2008.04.002. Epub 2008 Apr 22.

16.
17.

Controlled release of rhBMP-2 loaded poly(dl-lactic-co-glycolic acid)/calcium phosphate cement composites in vivo.

Ruhé PQ, Boerman OC, Russel FG, Spauwen PH, Mikos AG, Jansen JA.

J Control Release. 2005 Aug 18;106(1-2):162-71.

PMID:
15972241
18.

Preparation and property of a novel bone graft composite consisting of rhBMP-2 loaded PLGA microspheres and calcium phosphate cement.

Fei Z, Hu Y, Wu D, Wu H, Lu R, Bai J, Song H.

J Mater Sci Mater Med. 2008 Mar;19(3):1109-16. Epub 2007 Aug 15.

PMID:
17701313
19.

Quantitative assessment of scaffold and growth factor-mediated repair of critically sized bone defects.

Oest ME, Dupont KM, Kong HJ, Mooney DJ, Guldberg RE.

J Orthop Res. 2007 Jul;25(7):941-50.

20.

Porous silk fibroin 3-D scaffolds for delivery of bone morphogenetic protein-2 in vitro and in vivo.

Karageorgiou V, Tomkins M, Fajardo R, Meinel L, Snyder B, Wade K, Chen J, Vunjak-Novakovic G, Kaplan DL.

J Biomed Mater Res A. 2006 Aug;78(2):324-34.

PMID:
16637042
Items per page

Supplemental Content

Write to the Help Desk